683 Capital Management »

Proqr Thrapeutics N V shs euro shares owned by 683 Capital Management

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.6M 1.4M 1.86

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
NVIDIA Corporation Put Option (NVDA)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Capital One Financial (COF)
Abbvie Put Option (ABBV)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Anaptysbio Inc Common (ANAB)
Alnylam Pharmaceuticals (ALNY)
Uniqure Nv SHS (QURE)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Becton, Dickinson and (BDX)
Molina Healthcare (MOH)

View all positions for 683 Capital Management

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Standard Life Aberdeen
Affinity Asset Advisors
Privium Fund Management B.V.
Ikarian Capital
Woodline Partners
Heights Capital Management
Sphera Funds Management
Kynam Capital Management
DAFNA Capital Management
Squadron Capital Management
683 Capital Management
Morgan Stanley
Citadel Advisors
Platinum Investment Mangement

View all funds holding Proqr Thrapeutics N V shs euro